Salih Colakoglu, MD
Plastic and Reconstructive Surgery · Baltimore, MDNPI 1043509748
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,745 of the $4,480 with a category attached, or 83.6%. 10 manufacturers reported payments, led by TELA Bio, Inc. at 34.1% of the total. 2025 is the largest year on record at $1,755, more than ten times the $125 reported in 2019.
Across 33 payments — averaging $135.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$2K
- Davol Inc.$1K
- AbbVie$749
- Aroa Biosurgery Incorporated$207
- Axogen$205
- Kerecis Limited$203
- plus $558 from 4 others
Across 1 payment — averaging $27,302 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$27K
What the payments were for
- Travel & lodging$73516%
- Food & beverage$3,74584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 7 | $1,530 |
| Davol Inc. | 7 | $1,029 |
| AbbVie(2 entities) | 8 | $749 |
| Aroa Biosurgery Incorporated | 3 | $207 |
| Axogen | 2 | $205 |
| Kerecis Limited | 1 | $203 |
| Integra Lifesciences Corporation | 2 | $201 |
| BD | 1 | $200 |
| Endo Pharmaceuticals Inc. | 1 | $118 |
| Johnson & Johnson | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,401
- Phasix Mesh$803
- Kerecis Omega3 SurgiClose$610
- NATRELLE SALINE-FILLED BREAST IMPLANTS$424
- Surgiphor$338
- Kerecis Omega3 GraftGuide$203
- Kerecis Omega3 Marigen$203
- INTEGRA MESHED BILAYER WOUND MATRIX$144
- INTEGRA WOUND MATRIX (IWM)$144
- PRIMATRIX$144
- INTEGRA DERMAL REGENERATION TEMPLATE$144
- INTEGRA FLOWABLE WOUND MATRIX$144
- OviTex 2S$129
- STRATTICE$125
- XIAFLEX$118
How this compares
$4,480 in reported general payments places this provider in the 75th percentile of 55 plastic and reconstructive surgery providers in Maryland.
See all plastic and reconstructive surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Baltimore
- Kristen BroderickBaltimore$40K
- Branko BojovicBaltimore$19K
- Bernard ChangBaltimore$5K
- Brendan CollinsBaltimore$3K
- Robert LeskoBaltimore$3K
- Jennifer BaiBaltimore$2K
- Fan LiangBaltimore$2K
- Barkat AliBaltimore$2K
- Gedge RossonBaltimore$775
- Paul RingelmanBaltimore$40
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.